Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

BackgroundHyperuricemia has recently been identified as a risk factor of cardiovascular diseases; however, prognostic value of hyperuricemia in patients with ST-segment elevation myocardial infarction (STEMI) remained unclear. Simultaneously, the mechanism of this possible relationship has not been...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Xiao-Fang Tang, Chen He, Pei Zhu, Che Zhang, Ying Song, Jing-Jing Xu, Yi Yao, Na Xu, Ping Jiang, Lin Jiang, Zhan Gao, Xue-yan Zhao, Li-jian Gao, Lei Song, Yue-Jin Yang, Run-Lin Gao, Bo Xu, Jin-Qing Yuan
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2022-05-01
Edice:Frontiers in Endocrinology
Témata:
hyperuricemia
ST-segment myocardial infarction
percutaneous coronary intervention
long-term mortality
inflammatory response
On-line přístup:https://www.frontiersin.org/articles/10.3389/fendo.2022.852247/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky